SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-008703
Filing Date
2018-07-03
Accepted
2018-07-03 16:18:56
Documents
1
Period of Report
2018-06-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k062818_delmarpharma.htm 8-K 29418
  Complete submission text file 0001213900-18-008703.txt   30628
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 18937545
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1